Market Alert: Global Markets May Rebound Amid Signs of U.S. Economic Resilience

Confirmation of Acquisitions, Execution of NBIO, and Appointment of CFO

Oct 24, 2025

Prime Financial Group Ltd (ASX: PFG) has confirmed two strategic acquisitions, the execution of a Non-Binding Indicative Offer (NBIO) for a potential wealth acquisition, and the appointment of a new Chief Financial Officer (CFO). In its Business segment, Prime has acquired accounting clients generating approximately AU$1.2 million in annual revenue, with total consideration up to AU$2.52 million, including the issue of 4.3 million shares across four tranches.

In the Wealth segment, Prime has secured a business generating around AU$500,000 in annual revenue, with total consideration of up to AU$1.5 million and up to 2.63 million shares to be issued over four years. Additionally, Prime has executed a confidential NBIO to acquire a company providing investment research and fund management services, expected to contribute about AU$4 million in annual revenue if completed. Prime also announced the appointment of Sharon Papworth as CFO, effective 27 October 2025.

 

                                                                           

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com